SELB - Selecta Biosciences Inc - SEC Form 4 Insider Trading Screener
25 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| P | 9 | +0 | +0 | -22 | +27 |
| S | 5 | +0 | -4 | -17 | +0 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Share Price |
Shares Traded |
Shares Owned |
Own chg |
Value Traded |
1d ret |
1w ret |
1m ret |
6m ret |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AD | 2017-06-15 | SELB | Johnston Lloyd P. | COO, SVP, R, D | S - Sale+OE | $17.04 | -10,512 | 1,606 | -87% | -$179,141 | |||||
| D | 2017-07-03 | SELB | Johnston Lloyd P. | COO, SVP, R*D | S - Sale+OE | $19.10 | -5,959 | 1,606 | -79% | -$113,806 | |||||
| D | 2017-06-30 | SELB | Siewers David | CFO | S - Sale+OE | $20.00 | -7,420 | 0 | -100% | -$148,405 | |||||
| D | 2017-06-29 | SELB | Siewers David | CFO | S - Sale+OE | $20.00 | -9,652 | 0 | -100% | -$193,042 | |||||
| D | 2017-06-27 | SELB | Springer Timothy A | Dir | P - Purchase | $17.71 | +338,791 | 2,038,017 | +20% | +$5,999,989 | |||||
| D | 2017-06-27 | SELB | Keller Peter | Chief Business Officer | S - Sale+OE | $19.30 | -4,595 | 405 | -92% | -$88,681 | |||||
2017-06-26 | SELB | Siewers David | CFO | S - Sale | $20.00 | -6,886 | 36 | -99% | -$137,720 | ||||||
| D | 2017-06-15 | SELB | Johnston Lloyd P. | COO, SVP, R*D, 10% | S - Sale+OE | $17.00 | -20,512 | 1,606 | -93% | -$348,640 | |||||
2017-06-01 | SELB | Springer Timothy A | Dir | P - Purchase | $13.75 | +518 | 1,699,226 | 0% | +$7,123 | ||||||
| M | 2017-05-17 | SELB | Springer Timothy A | Dir | P - Purchase | $14.00 | +16,104 | 1,698,708 | +1% | +$225,523 | |||||
2017-05-16 | SELB | Kania Edwin M Jr | Dir | S - Sale | $14.00 | -266,795 | 586,595 | -31% | -$3,735,130 | ||||||
| D | 2017-04-17 | SELB | Johnston Lloyd P. | COO, SVP, R, D | S - Sale+OE | $13.95 | -13,205 | 1,606 | -89% | -$184,210 | 0 | -6 | |||
| D | 2017-01-23 | SELB | Johnston Lloyd P. | COO, SVP, R, D | S - Sale+OE | $14.01 | -15,000 | 1,606 | -90% | -$210,106 | -2 | 0 | -8 | ||
| D | 2016-12-28 | SELB | Kishimoto Takashi Kei | Chief Scientific Officer | S - Sale+OE | $17.55 | -10,000 | 0 | -100% | -$175,500 | +1 | -4 | -18 | ||
| D | 2016-12-21 | SELB | Abraham David | CCO, Gen.Counsel, Corp.Sec. | S - Sale+OE | $18.00 | -14,844 | 0 | -100% | -$267,192 | +2 | -6 | -21 | ||
2016-12-19 | SELB | Keller Peter | Chief Business Officer | S - Sale | $18.58 | -4,723 | 405 | -92% | -$87,753 | 0 | -6 | -21 | |||
| D | 2016-06-27 | SELB | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $14.00 | +550,000 | 1,825,415 | +43% | +$7,700,000 | 0 | 0 | -22 | +27 | |
| D | 2016-06-27 | SELB | Rusnano | 10% | P - Purchase | $14.00 | +107,143 | 1,476,177 | +8% | +$1,500,002 | 0 | 0 | -22 | +27 | |
| D | 2016-06-27 | SELB | Gordon Carl L | Dir, 10% | P - Purchase | $14.00 | +550,000 | 1,825,415 | +43% | +$7,700,000 | 0 | 0 | -22 | +27 | |
| D | 2016-06-27 | SELB | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $14.00 | +550,000 | 1,825,415 | +43% | +$7,700,000 | 0 | 0 | -22 | +27 | |
| D | 2016-06-27 | SELB | Osage University Partners Ii, L.P. | 10% | P - Purchase | $14.00 | +350,000 | 862,543 | +68% | +$4,900,000 | 0 | 0 | -22 | +27 | |
| D | 2016-06-27 | SELB | Nanodimension Management Ltd | 10% | P - Purchase | $14.00 | +385,000 | 1,045,957 | +58% | +$5,390,000 | 0 | 0 | -22 | +27 | |
| D | 2016-06-27 | SELB | Tas Partners, LLC | Dir | P - Purchase | $14.00 | +710,000 | 1,237,028 | +135% | +$9,940,000 | 0 | 0 | -22 | +27 | |
| D | 2016-06-27 | SELB | Nashat Amir | Dir, 10% | P - Purchase | $14.00 | +150,000 | 1,836,703 | +9% | +$2,100,000 | 0 | 0 | -22 | +27 | |
| D | 2016-06-27 | SELB | Polaris Venture Management Co. V, L.L.C. | 10% | P - Purchase | $14.00 | +150,000 | 1,836,703 | +9% | +$2,100,000 | 0 | 0 | -22 | +27 |
Real-time CSV? Options? Alerts? Contact us!
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |